Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471776) titled 'Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer' on March 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Fudan University
Condition:
Metastatic Breast Cancer ( HER2 Negative)
Intervention:
Drug: Sacituzumab Govitecan?Datopotamab deruxtecan?Sacituzumab tirumotecan
Diagnostic Test: 68Ga-TROP2 PET/CT Imaging
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: March 11, 2026
Target Samp...